A Blueprint for Supply Chain Success
June 26, 2020
A policy framework aims to boost the manufacture of critical drugs in the USA
1 min read
June 2020
In this month’s issue, our cover feature examines how travel bans have affected the clinical trial landscape. Meanwhile, thought leaders from across the industry share their thoughts on the COVID-19 outbreak in In My View's Pandemic Diaries. In NextGen, we look into the benefits of 3D cell culture assays, and for Sitting Down With, we interview Paul Peter Tak, President and CEO at Kintai Therapeutics, on how research into the microbiome has accelerated in recent years.
Airplane Blues
June 24, 2020
With many planes grounded, strict travel bans, and stay at home orders enforced in many countries, how is the clinical trials industry recruiting patients, conducting studies, and distributing products in the thick of the COVID-19 pandemic?
1 min read
The COVID-19 Curator
June 23, 2020
Your roundup of the key scientific studies and industry announcements emerging from the pandemic
0 min read
Biopharma Banding Together
June 22, 2020
How has the COVID-19 pandemic changed the industry? And how can we respond faster next time?
0 min read
Branching Out
June 20, 2020
Energy-saving hardware could reduce the carbon footprint of AI-driven drug development
0 min read
Preventing the Viral Trigger Pull
June 19, 2020
A new vaccine protects against type 1 diabetes in animal models
0 min read
Trial Ready
June 19, 2020
The University of Oxford receives its first batch of AZD1222, a coronavirus vaccine candidate.
0 min read
ADCs on the Rise
June 18, 2020
After the successes of 2019, will the antibody-drug conjugate sector continue to progress?
1 min read
Keeping the Show on the Road
June 18, 2020
The COVID-19 pandemic has put additional supply pressures on cold-chain products, such as those encapsulated by LNPs – but delays can be avoided with sufficient safety stocks, additional suppliers, and good communication.
0 min read
Making Money Through M&As
June 17, 2020
Do pharma mergers and acquisitions improve R&D productivity and increase shareholder value?
0 min read
Access Not Denied
June 15, 2020
Any diagnostics, treatments and vaccines developed to combat COVID-19 must be suitable for use in all countries, including resource-poor settings
0 min read
Business & Regulation
Facilities & Equipment
Regulation & Standards
Business & Trends
Technology & Manufacturing
The Digital Review
June 12, 2020
It’s time to address the bottlenecks that lie in quality assurance review and release – and digital systems can help us
0 min read
Calming the Cytokine Storm
June 11, 2020
How salivary compounds produced by blood-sucking parasites could be a good thing…
0 min read
Going with Your Gut Instinct
June 5, 2020
Sitting Down With… Paul Peter Tak, President and CEO at Kintai Therapeutics
0 min read
Manufacture
Facilities & Equipment
Technology & Manufacturing
Bioprocessing
Biopharma
Drug Discovery
Research News
Dimensions of Progress
June 4, 2020
How far along is the pharmaceutical industry in its journey with 3D cell culture technologies?
0 min read
The Human Touch
June 3, 2020
In the midst of a global pandemic, ensuring the safety of employees is paramount
0 min read
